Regulation and deregulation of cholangiocyte proliferation

Journal of Hepatology

Volumn 33, Issue 2, 2000, Pages 333-340

  Alvaro, Domenico ^a,b   Gigliozzi, Alessandro ^a   Attili, Adolfo F ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Div Gastroenterol   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; SCATTER FACTOR; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; BILE DUCT; CELL PROLIFERATION; CHOLESTATIC HEPATITIS; CYTOKINE PRODUCTION; DEREGULATION; EPITHELIUM CELL; HORMONAL REGULATION; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

EID: 0033929404     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80377-3     Document Type: Review

References (86)

1. Roberts SK, Ludwig J, Larusso NF. The pathobiology of biliary epithelia. Gastroenterology. 112:1997;269-279.
2. Strazzabosco M. New insights into cholangiocyte physiology. J Hepatol. 27:1997;945-952.
3. Kanno N, LeSage G, Glaser S, Alvaro D, Alpini G. Functional heterogeneity of the intrahepatic biliary epithelium. Hepatology. 31:2000;555-561.
4. Boyer JL. Vanishing Bile Duct Syndrome - from bench to bed side. Alvaro D, Benedetti A, Strazzabosco M. Vanishing Bile Duct Syndrome. 1997;240-246 Kluwer Academic Publishers, London.
5. Alvaro D. Biliary epithelium: a new chapter in cell biology. It J Gastroenterol Hepatol. 31:1999;78-83.
6. Alpini G, Lenzi R, Sarkozi L, Tavoloni N. Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules. J Clin Invest. 81:1988;569-578.
7. Desmet V, Roskams T, Van Eyken P. Histopathology of vanishing bile duct diseases. Adv Clin Pathol. 2:1998;87-99.
8. Desmet V, Roskams T, Van Eyken P. Ductular reaction in the liver. Path Res Pract. 191:1995;513-524.
9. Desmet V, Roskams T, Van Eyken P. Pathology of the biliary tree in cholestasis: ductular reaction. Manns MP, Boyer JL, Jansen PLM, Reichen J. Cholestatic Liver Diseases. 1998;143-154 Kluwer Academic Publishers, London.
10. Uchida T, Peters RL. The nature and origin of proliferated bile ductules in alcoholic liver. Am J Clin Pathol. 79:1983;326-333.
11. Knowles DM, Wolff M. Focal nodular hyperplasia of the liver: a clinicopathologic study and review of the literature. Hum Pathol. 7:1976;533-545.
12. Miller DJ, Keeton DG, Webber BL, Pathol FF, Saunders SJ. Jaundice in severe bacterial infection. Gastroenterology. 71:1976;94-97.
13. Celli A, Que FG. Dysregulation of apoptosis in the cholangiopathies and cholangiocarcinoma. Semin Liver Dis. 2:1998;177-185.
14. LeSage G, Glaser S, Gubba S, Robertson WE, Phinizy JL, Lasater J, et al. Regrowth of the rat biliary tree after 70% partial hepatectomy is coupled to increased secretin-induced ductal bile secretion. Gastroenterology. 111:1996;1633-1644.
15. Goldfarb S, Singer EJ, Popper H. Experimental cholangitis due to a-naphthylisothiocyanate (ANIT). Am J Path. 40:1962;585-598.
16. Vacanti JP, Folkman J. Bile duct enlargement by infusion of L-proline: potential significance in biliary atresia. J Pediatr Surg. 14:1979;814-818.
17. Palmer RH, Ruban Z. Production of bile duct hyperplasia and gallstones by lithocholic acid. J Clin Invest. 45:1966;1255-1267.
18. Alpini G, Glaser S, Ueno Y, Phinizy JL, Rodgers R, Francis H, et al. Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion. Gastroenterology. 116:1999;179-186.
19. James L, Lygidakis NJ, van Eyken P, Tanka AK, Bosch KS, Ramaekers FC, et al. Application of keratin immunocytochemistry and sirius red staining in evaluation of intrahepatic changes with acute extrahepatic cholestasis due to hepatic duct carcinoma. Hepato-Gastroenterology. 36:1989;151-155.
20. Slott PA, Liu MH, Tavoloni N. Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat. Gastroenterology. 99:1990;466-477.
21. Grisham JW. A morphological study of deoxyribonucleic acid synthesis and cell proliferation, in regenerating rat liver: autoradiography with thymidine-H3. Cancer Res. 22:1962;842-849.
22. Omori M, Evarts RP, Omori N, Hu Z, Marsden ER, Thorgeirsson SS. Expression of α-feto-protein and stem cell factor/c-kit system in BDL young rats. Hepatology. 25:1997;1115-1122.
23. Kuhlmann WD, Wurster K. Correlation of histology and alpha 1-fetoprotein resurgence in rat liver regeneration after experimental injury by galactosamine. Virchows Arch A Pathol Anat Histol. 387:1980;47-57.
24. LeSage GD, Benedetti A, Glaser S, Marucci L, Tretjak Z, Caligiuri A, et al. Acute carbon tetrachloride feeding selectively damages large, but not small, cholangiocytes from normal rat liver. Hepatology. 29:1999;307-319.
25. Desmet VJ. Current problems in diagnosis of biliary disease and-cholestasis. Semin Liv Dis. 6:1986;233-245.
26. Fausto N, Webber EM. Liver regeneration. Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter D, Shafritz DA. The Liver: Biology and Pathobiology. 3rd ed. 1994;1059-1084 Raven Press, Ltd. New York.
27. Nagore N, Howe S, Boxer L, Scheuer PJ. Liver cell rosettes: structural differences in cholestasis and hepatitis. Liver. 9:1989;43-51.
28. Wegmann R, Corcos V, Caroli J. Histoenzymologie des ductules biliaires chez l'embryon humain normal et au cours des cirrhoses humaines. Arch Mal Appar Dig. 54:1967;215-228.
29. Yamada S, Howe s, Scheuer PJ. Three-dimensional reconstruction of biliary pathways in primary biliary cirrhosis: a computer-assisted study. J Pathol. 152:1987;317-323.
30. Hillan KJ, Burt AD, George WD, Macsween RN, Grifiths MR, Bradley JA. Intrasplenic hepatocytes transplantation in rats with exprerimental liver injury: morphological and morphometric studies. J Pathol. 159:1989;67-73.
31. Scarpelli DG. Multipotent developmental capacity of cells in the adult animal. Lab Invest. 52:1985;331-333.
32. Roskams T, Van den Oord JJ, De Vos R, Desmet VJ. Neuroendocrine features or reactive bile ductules in cholestatic liver disease. Am J Pathol. 137:1990;1019-1025.
33. Roskams T, Campos RV, Drucker DJ, Desmet V. Reactive human bile ductules express parathyroid hormone-related peptide. Histopathology. 23:1993;11-19.
34. A receptors on large cholangiocytes. Am J Physiol. 275:1998;G835-G846.
35. Petropoulos CJ, Yaswen P, Panzica M, Fausto N. Cell lineages in liver carcinogenesis: possible clues from studies of the distribution of alpha-fetoprotein RNA sequences in cell populations isolated from normal, regenerating, and preneoplastic rat livers. Cancer Res. 43:1985;5762-5768.
36. Sirica AE, Cihla HP. Isolation and partial characterizations of oval and hyperplastic bile ductular cell-enriched populations from the livers of carcinogen and noncarcinogen-treated rats. Cancer Res. 44:1984;3454-3466.
37. Farber E. Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetyl-aminofluorene, and 3′-methyl-4-dimethyl-aminoazobenzene. CancerRes. 16:1956;142-148.
38. Farber E. The sequential analysis of cancer induction with chemicals. Acta Pathol Japonica. 31:1981;1-11.
39. Polimeno L, Azzarone A, Zeng QH, Panella C, Subbotin V, Carr B, et al. Cell proliferation and oncogene expression after bile duct ligation in the rat: evidence of a specific growth effect on bile duct cells. Hepatology. 21:1995;1070-1088.
40. Joplin R, Hishida T, Tsubouchi H, Daikuhara Y, Ayres R, Neuberger JM, et al. Human intrahepatic biliary epithelial cells proliferate in vitro in response to human hepatocyte growth factor. J Clin Invest. 90:1992;1284-1289.
41. Matsumoto K, Fuji H, Michalopoulos G, Fung JJ, Demetris AJ. Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factor in vitro: interleukin-6, hepatocyte growth factor factor promote DNA synthesis in vitro. Hepatology. 20:1994;376-382.
42. Liu Z, Sakamoto T, Ezure T, Yokomuro S, Murase N, Michalopoulos G, et al. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium. Hepatology. 28:1998;1260-1268.
43. Napoli J, Prentice D, Niinami C, Bishop GA, Desmond P, McCaughan GW. Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and TGF-beta in a bile duct ligated rat model of cirrhosis. Hepatology. 26:1997;624-633.
44. Michalopoulos GK. Liver regeneration: molecular mechanisms of growth control. FASEB J. 4:1990;176-187.
45. Wilson JW, Leduc EH. Role of cholangioles in restoration of the liver of the mouse after dietary injury. J Pathol Bacteriol. 76:1958;441-449.
46. Paradis K, Le ON, Russo P, St-Cyr M, Fournier H, Bu D. Characterization and response to interleukin 1 and tumor necrosis factor of immortalized murine biliary epithelial cells. Gastroenterology. 109:1995;1308-1315.
47. Morland CM, Fear J, Joplin R, Adams DH. Human biliary epithelial cels express chemokines interleukine-8 and monocyte chemotactic protein-1 in response to inflammatory cytokine stimulation. Hepatology. 24:(suppl):1996;332A.
48. Malizia G, Brunt EM, Peters MG, Rizzo A, Broekelmann TJ, McDonald JA. Growth factor and procollagen type I gene expression in human liver disease. Gastroenterology. 1995;145-156.
49. Fukuda Y, Imoto M., Koyama Y. Immunohistochemical study on tissue inhibitors of metalloproteinases in normal and pathological human livers. Gastroenterol Jap 191; 26: 37-41.
50. Mano Y, Ishii M, Okamoto H, Igarashi T, Kobayashi K, Toyota T. Effect of tumor necrosis factor alpha on intrahepatic bile duct epithelial cells of rat liver. Hepatology. 23:1996;1602-1607.
51. LeSage G, Alvaro D, Benedetti A, Glaser S, Marucci L, Eisel W, et al. Cholinergic system modulates growth, apoptosis and secretion of cholangiocytes from bile duct ligated rats. Gastroenterology. 117:1999;191-199.
52. Yang L, Faris RA, Hixson DC. Long-term culture and characteristics of normal rat liver bile duct epithelial cells. Gastroenterology. 104:1993;840-852.
53. Tanaka J, Koshimura K, Murakami Y, Yanaihara N, Kata Y. Neuronal protection from apoptosis by pituitary adenylate cyclase-activating polypeptide. Regul Pept. 71:1997;1-8.
54. Iwai M, Shimazu T. Alteration in sympathetic nerve activity during liver regeneration in rats after partial hepatectomy. J Auton Nerv Syst. 41:1992;209-214.
55. Glaser S, LeSage G, Alvaro D, Chowdhury U, Kanno N, Francis H, et al. Ablation of the D2 dopaminergic innervation by intraportal injection of 6-hydroxidopamine (6-OHDA) reduces cholangiocyte proliferative and secretory activity in bile duct ligated (BDL) rats. Hepatology. 30:1999;A1088.
56. Tietz P, Alpini G, Pham LD, LaRusso NF. Somatostatin inhibits secretin-induced ductal choleresis in vivo and exocytosis by cholangiocytes. Am J Physiol. 269:1995;G110-G118.
57. Tan CK, Podila PV, Taylor JE, Nagorney DM, Wiseman GA, Gores GJ, et al. Human cholangiocarcinomas express somatostatin receptors and respond to somatostatin with growth inhibition. Gastroenterology. 108:1995;1908-1916.
58. Glaser SS, Rodgers R, Phinizy JL, Robertson WE, Lasater J, Caligiuri A, et al. Gastrin inhibits secretin-induced ductal secretion by interaction with specific receptors on rat cholangiocytes. Am J Physiol. 273:1997;G1061-G1070.
59. Detjen K, Fenrich MC, Logsdon CD. Transfected cholecystokin-in receptors mediate growth inhibitory effects on human pancreatic cancer cell lines. Gastroenterology. 112:1997;952-959.
60. Glaser S, Eisel W, Baiocchi L, Francis H, Phinizy JL, Kanno N, et al. Gastrin inhibits cholangiocyte growth and secretion in bile duct ligated (BDL) rats by interaction with CCK-B/gastrin receptors via a PKC-, Ca2+-dependent. Hepatology. 2000;. in press.
61. Kanno N, LeSage G, Glaser S, Chowdury U, Phinizy JL, Eisel W, et al. Gastrin inhibits growth and induces apoptosis of cholangiocarcinoma Mz-ChA-1 cells associated with membrane translocation of PKCa. Hepatology. 30:1999;A1084.
62. LeSage G, Glaser S, Caligiuri A, Phinizy J, Rodgers R, Francis H, et al. Insulin inhibits secretin-stimulated ductal bile secretion in bile duct ligated (BDL) rats by interaction with insulin receptors on cholangiocytes. Gastroenterology. 114:1998;L0367.
63. Alvaro D, Alpini G, Onori P, Perego L, Svegliati Baroni G, Franchitto A, et al. The role of estrogens in the regulation of proliferative capacity of intrahepatic biliary epithelium in rats. Gastroenterology. 2000;. in press.
64. Joplin R, Neuberger JM. Antigen expression in bile duct epithelia in cholestatic liver disease. Manns MO, Boyer JL, Jansen PLM, Reichen J. Cholestatic Liver Diseases. 1998;226-238 Falk Symposium 102. Kluwer Academic Publ. Dordrecht/Boston/London.
65. Lindor KD. Sex hormone changes in post-menopausal women with primary biliary cirrhosis (PBC) and with cryptogenic chronic liver disease. Semin Liver Dis. 13:1993;367-373.
66. Sampson LK, Vickers SM, Ying W, Phillips JO. Tamoxifen-mediated growth inhibition of human cholangiocarcinoma. Cancer Res. 57:1997;1743-1749.
67. Alpini G, Glaser S, Robertson W, Phinizy JL, Rodgers R, Caligiuri A, et al. Bile acids stimulate proliferative and secretory events in large but not small cholangiocytes. Am J Physiol. 273:1997;G518-G529.
68. Baiocchi L, Alpini G, Glaser S, Eisel W, Francis H, Phinizy JL, et al. The inhibitory effect of ursodeoxycholate (UDCA) on cholangiocyte growth and secretion in bile duct ligated (BDL) rats is not affected by its conjugation with taurine. Gastroenterology. 116:1999;AL0033.
69. Alpini G, Glaser S, Phinizy JL, Rodgers R, Robertson W, Caligiuri A, et al. Bile acid depletion decreases cholangiocyte proliferative capacity and secretin-stimulated ductal bile secretion in bile duct ligated (BDL) rats. Gastroenterology. 112:1997;A1210.
70. Beuers U, Boyer JL, Paumgartner G. Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic applications. Hepatology. 28:1998;1449-1453.
71. Bhathal PS, Gall JAM. Deeletion of hyperplastic biliary epithelial cells by apoptosis following removal of the proliferative stimulus. Liver. 5:1985;311-325.
72. Charlotte F, L'Hermine A, Martin N, Geleyn Y, Nollet M, Gaulard P, et al. Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Am J Pathol. 144:1994;460-465.
73. Stähelin BJ, Zimmermann H, Reichen J. The balance of Bax and Bcl-2 regulates apoptosis in biliary epithelial cells (BEC). J Hepatol. 26:(Suppl 1)):1996;67.
74. Que FG, Gores GJ, LaRusso NF. Development and initial application of an in vitro model of apoptosis in rodent cholangiocytes. Am J Physiol. 272:1997;G106-G115.
75. Que FG, Phan VA, Phan VH, LaRusso NF, Gores GJ. GUDC inhibitscytochrome c release from human cholangiocyte mitochondria. J Surg Res. 83:1999;100-105.
76. Celli A, Que FG, Gores GJ, LaRusso NF. Glutathione depletion is associated with decreased Bcl-2 expression and increased apoptosis in cholangiocytes. Am J Physiol. 275:1998;G749-G757.
77. Kuroki T, Seki S, Kawakita N, Nakatani K, Hisa T. Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis. Virchows Arch. 429:1996;119-129.
78. Marucci L, Jezequel AM, Benedetti A. Biliary epithelium injury and death in primary biliary cirrhosis. J Hepatol. 30:1999;105A.
79. Chen XM, Gores GJ, Paya CV, LaRusso NF. Cryptosporidium parvum induces apoptosis in bilia-ry epithelia by a Fas/Fas ligand-dependent mechanism. Am J Physiol. 277:1999;G599-G608.
80. Harnois DM, Que FG, Celli A, LaRusso NF, Gores GJ. Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line. Hepatology. 26:1997;884-890.
81. Fiorentino M, D'Errico A, Altimari A, Barozzi C, Grigioni WF. High levels of BCL-2 messenger RNA detected by in situ hybridization in human hepatocellular and cholangiocellular carcinomas. Diagn Mol Pathol. 8:1999;189-194.
82. Ohashi K, Nakajima Y, Kanehiro H, Tsutsumi M, Taki J, Aomatsu Y, et al. K-ras mutations and p-53 protein expressions in intra-hepatic cholangiocarcinomas: relation to tumor morphology. Gastroenterology. 109:1995;1612-1617.
83. Que FG, Phan VA, Phan VH, Celli A, Batts K, LaRusso NF, et al. Cholangiocarcinomas express Fas ligand and disable the Fas receptor. Hepatology. 30:1999;1398-1404.
84. Pickens A, Pan G, McDonald J, Vickers SM. Fas expression prevents cholangiocarcinoma tumor growth. J Gastrointest Surg. 3:1999;374-382.
85. Park J, Tadlock L, Gores GJ, Patel T. Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line. Hepatology. 30:1999;1128-1133.
86. Jaiswal M, LaRusso NF, Burgart LJ, Gores GJ. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res. 60:2000;184-190.